• Low-grade
  • 掕宆揑僇儖僠僲僀僪
• Intermediate-grade
  • 旕掕宆揑僇儖僠僲僀僪
• High-grade
  • 戝嵶朎恄宱撪暘斿娻
  • 彫嵶朎娻

• 僇儖僠僲僀僪庮釃
• 彫嵶朎娻
  • 墠敒嵶朎娻
  • 拞娫嵶朎宆

栤戣揰
戝嵶朎恄宱撪暘斿娻偲彫嵶朎娻偵娭偟偰丄昦棟堛娫偺恌抐堦抳棪偑掅偄偙偲偑曬崘偝傟偰偄傑偡丅 Travis傜偼丄摨偠昗杮傪俆恖偺攛愱栧偺昦棟堛偱恌抐偟傑偟偨丅彫嵶朎娻丄戝嵶朎恄宱撪暘斿娻偺慡椺偱俁恖埲忋偺恌抐偑堦抳偟傑偟偨丅慡堳偑堦抳偟偨偺偼丄彫嵶朎娻偺俈妱丄戝嵶朎恄宱撪暘斿娻偺係妱偱偟偨丅係恖偑堦抳偟偨偺偼彫嵶朎娻偺俋妱丄戝嵶朎恄宱撪暘斿娻偺俆妱偱偟偨[10]丅

堷梡暥專

1. Hiroshima K, Iyoda A, Shibuya K, Hoshino H, Haga Y, Toyozaki T, Shiba M, Baba M, Fujisawa T, Ohwada H. Evidence of neoangiogenesis and an increase in the number of proliferating cells within the bronchial epithelium of smokers. Cancer 95, 1539-1545, 2002
2. Nakatani Y, Kitamura H, Inayama Y, Kamijo S, Nagashima Y, Shimoyama K, Nakamura N, Sano J, Ogawa N, Shibagaki T, Resl M, Mark EJ. Pulmonary adenocarcinomas of the fetal lung type: a clinicopathologic study indicating differences in histology, epidemiology, and natural history of low-grade and high-grade forms. Am. J. Surg. Pathol. 22, 399-411, 1998
3. Nakatani Y, Masudo K, Miyagi Y, Inayama Y, Kawano N, Tanaka Y, Kato K, Ito T, Kitamura H, Nagashima Y, Yamanaka S, Nakamura N, Sano J, Ogawa N, Ishiwa N, Notohara K, Resl M, Mark EJ. Aberrant nuclear localization and gene mutation of beta-catenin in low-grade adenocarcinoma of fetal lung type: up-regulation of the Wnt signaling pathway may be a common denominator for the development of tumors that form morules. Mod. Pathol. 15, 617-24, 2002
4. Iyoda A, Hiroshima K, Toyozaki T, Tsukamoto Y, Haga Y, Fujisawa T, Ohwada H. Clear cell adenocarcinoma with endobronchial polypoid growth. Pathol. Int. 50, 979-983, 2000
5. Hiroshima K, Shibuya K, Shimamura F, Toyozaki T, HagaY, Ohwada H, Iyoda A, Sekine Y, Iizasa T, Fujisawa T. Pulmonary large cell carcinoma with rhabdoid phenotype. Ultrastruct. Pathol. 27, 55-59, 2003
6. Hiroshima K, Abe S, Ebihara Y, Ogura S, Kikui M, Kodama T, Komatsu H, Saito Y, Sagawa M, Sato M, Tagawa Y, Nakamura S, Nakayama T, Baba M, Hanzawa S, Hirano T, Horai T. Cytological characteristics of pulmonary large cell neuroendocrine carcinoma. Lung Cancer 48, 331-7, 2005
7. Iyoda A, Hiroshima K, Toyozaki T, Haga Y, Fujisawa T, Ohwada H. Clinical characterization of pulmonary large cell neuroendocrine carcinoma and large cell carcinoma with neuroendocrine morphology. Cancer 91, 1992-2000, 2001
8. Iyoda A, Hiroshima K, Baba M, Saitoh Y, Ohwada H, Fujisawa T. Pulmonary large cell carcinomas with neuroendocrine features are high-grade neuroendocrine tumors. Ann. Thorac. Surg. 73, 1049-1054, 2002
9. Iyoda A, Hiroshima K, Toyozaki T, Haga Y, Baba M, Fujisawa T, Ohwada H. Adjuvant chemotherapy for large cell carcinoma with neuroendocrine features. Cancer 92, 1108-1112, 2001
10. Travis WD, Gal AA, Colby TV, Klimstra DS, Falk R, Koss MN. Reproducibility of neuroendocrine lung tumor classification. Hum Pathol. 29, 272-279, 1998
11. Hiroshima K, Ishibashi M, Ohwada H, Kawano Y, Mizutani F, Hayashi Y. A case of adenocarcinoma of the lung with a spindle cell component. Acta Pathol. Jpn. 42, 841-846, 1992
12. Nakatani Y, Miyagi Y, Takemura T, Oka T, Yokoi T, Takagi M, Yokoyama S, Kashima K, Hara K, Yamada T, Nozawa A, Inayama Y, Sakamoto K, Ogawa N, Kitamura H, Resl M, Cho SH, Koss MN, Mark EJ. Aberrant nuclear/cytoplasmic localization and gene mutation of beta-catenin in classic pulmonary blastoma: beta-catenin immunostaining is useful for distinguishing between classic pulmonary blastoma and a blastomatoid variant of carcinosarcoma. Am. J. Surg. Pathol. 28, 921-7, 2004

杮峞偵宖嵹偝傟偰偄傞尠旝嬀幨恀側偳偼丄屄恖偱巊梡偝傟傞応崌偼丄偛帺桼偵僟僂儞儘乕僪偟偰偄偨偩偄偨寢峔偱偡丅偨偩偟丄岞昞偝傟傞応崌傗儕儞僋傪偝傟傞応崌偼丄弌揟傪柧傜偐偵偟偰偔偩偝偄丅